First Horizon Advisors, Inc. Harmony Biosciences Holdings, Inc. Transaction History
First Horizon Advisors, Inc.
- $3.55 Billion
- Q4 2024
A detailed history of First Horizon Advisors, Inc. transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, First Horizon Advisors, Inc. holds 34 shares of HRMY stock, worth $1,175. This represents 0.0% of its overall portfolio holdings.
Number of Shares
34
Previous 34
-0.0%
Holding current value
$1,175
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding HRMY
# of Institutions
255Shares Held
46.6MCall Options Held
119KPut Options Held
50K-
Valor Management LLC Chicago, IL6.62MShares$229 Million92.04% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$202 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.73MShares$164 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.28MShares$78.8 Million0.19% of portfolio
-
State Street Corp Boston, MA1.58MShares$54.6 Million0.0% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $2.04B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...